Bio-Path Holdings (BPTH) Misses Q3 EPS by 3c

Bio-Path Holdings (NASDAQ: BPTH) reported Q3 EPS of ($0.49), $0.03 worse than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.

You May Also Be Interested In

• Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?
• nVent Electric (NVT) PT Raised to $225 at UBS as Momentum Expected to Carry Through 2027
• Under Armour, Inc. (UAA) PT Raised to $8 at Williams Trading